化合物CVT313 T3195
品牌 | 厂商性质 | 产地 | 货期 |
---|---|---|---|
TargetMol | 生产商 | 美国 | 现货 |
性能特点
生化试剂,可用于动物细胞实验
规格 | CAS号 | 价格 | 操作 |
---|---|---|---|
25 mg | 199986-75-9 | ¥1,930.00 | 询底价 |
10 mg | 199986-75-9 | ¥987.00 | 询底价 |
2 mg | 199986-75-9 | ¥383.00 | 询底价 |
1 mg | 199986-75-9 | ¥273.00 | 询底价 |
50 mg | 199986-75-9 | ¥3,570.00 | 询底价 |
100 mg | 199986-75-9 | ¥4,970.00 | 询底价 |
5 mg | 199986-75-9 | ¥678.00 | 询底价 |
1 mL | 199986-75-9 | ¥691.00 | 询底价 |
Product Introduction
Bioactivity
英文名: CVT-313
描述: CVT-313 (NG26) 是一种有效的、选择性的、可逆的和 ATP 竞争性抑制剂,可抑制 CDC5L 磷酸化,对 CDK2的 IC50为 0.5 μM。
细胞实验: CVT313 is prepared in DMSO and stored, and then diluted with appropriate medium before use[2]. MRC-5 cells are grown in Dulbecco's modified Eagle's medium containing 5% fetal calf serum. CVT313 (0, 5, 10, 15 μM) is added to exponentially growing cells in tissue culture. Cell population is measured. Proliferation assays are carried out using the nonradioactive CellTiter 96 kit after 48-h exposure. For FACS analysis of DNA content, cells are trypsinized, fixed in 70% ice-cold ethanol, and treated with 0.1 mg/mL RNase A and 40 μg/mL propidium iodide for 1 h at 37°C[2].
激酶实验: For kinase assays, purified CDC5L(295-795)-His6 is mixed with [γ-32P]ATP, COS-7 cell extract, and incubated in 100 μL 20 mM HEPES, pH 7.5, 50 mM NaCl, 2 mM MnCl2, 10 mM MgCl2, 0.5% NP-40, 0.5 mM PMSF, 5 mM benzamidine hydrochloride, 5 mM NaF, 1 mM NaVO3 and the specific inhibitor at 30°C for 10 minutes. Cell extract as a source of kinase activity is prepared from subconfluent, serum-stimulated COS-7 cells lysed in 20 mM HEPES-NaOH, pH 7.5, 50 mM NaCl, 1% Triton X-100, 10% glycerol, protease and phosphotase inhibitors. Phosphorylated proteins are separated by electrophoresis in 15% polyacrylamide-SDS gels. Specific inhibitors included 20 μM staurosporine, 10 μM genistein, 1 μM CVT-313, 10 μM Rp-MB-cAMPS and 50 μM PD98059[1].
体外活性: CVT-313 has been shown to inhibit other kinases, but at much higher IC50 values, i.e., CDK1 (IC50=4.2 μM), CDK4 D1 (IC50=215 μM), and MAPK/PKA/PKC (IC50>1.25 mM), compared to CDK2 (IC50=0.5 μM). CVT-313 has been shown to have profound effects on cell proliferation at concentrations of 5-20 μM[1]. CVT-313 is a potent CDK2 inhibitor, which is identified from a purine analog library with an IC50 of 0.5 μM in vitro. Inhibition is competitive with respect to ATP (Ki=95 nM), and selective CVT-313 has no effect on other, nonrelated ATP-dependent serine/threonine kinases. When added to CDK1 or CDK4, a 8.5- and 430-fold higher concentration of CVT-313 is required for half-maximal inhibition of the enzyme activity. Using normal and tumor human/murine cell lines, the effects of CVT-313 on cell proliferation is measured. The IC50 for growth inhibition ranged from 1.25 to 20 μM[2].
存储条件: Powder: -20°C for 3 years | In solvent: -80°C for 1 year
溶解度: DMSO : 50 mg/mL (124.85 mM)
关键字: inhibit | CDK | Cyclin dependent kinase | NG-26 | CVT-313 | NG 26 | Inhibitor
相关产品: Indomethacin-D4 | NVP-LCQ195 | Mevociclib | CDK9-Cyclin T1 PPI-IN-1 | SCH900776 | HQ461 | 1-NM-PP1 | CDK9 inhibitor HH1 | Ribociclib | Indirubin-3'-monoxime
相关库: Anti-Prostate Cancer Compound Library | Anti-Breast Cancer Compound Library | Cell Cycle Compound Library | Anti-Cancer Compound Library | Bioactive Compounds Library Max | Kinase Inhibitor Library | Inhibitor Library | Anti-Pancreatic Cancer Compound Library | NO PAINS Compound Library | Bioactive Compound Library
化合物CVT313 T3195信息由TargetMol中国为您提供,如您想了解更多关于化合物CVT313 T3195报价、型号、参数等信息,欢迎来电或留言咨询。
注:该产品未在中华人民共和国食品药品监督管理部门申请医疗器械注册和备案,不可用于临床诊断或治疗等相关用途